• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶体铁药物产品(蔗糖铁)的药物特征描述和热力学稳定性评估

Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose.

机构信息

Food and Drug Administration, Center for Drug Evaluation and Research Office of Testing and Research, Division of Product Quality Research, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States.

Food and Drug Administration, Center for Drug Evaluation and Research Office of Generic Drugs, 7500 Standish Place, Rockville, MD 20855, United States.

出版信息

Int J Pharm. 2014 Apr 10;464(1-2):46-52. doi: 10.1016/j.ijpharm.2014.01.008. Epub 2014 Jan 17.

DOI:10.1016/j.ijpharm.2014.01.008
PMID:24440404
Abstract

The study objective was to evaluate the thermodynamic stability of iron sucrose complexes as determined by molecular weight (m.w.) changes. The first part of the study focused on the effect of thermal stress, pH, electrolyte or excipient dilution on the stability of a colloidal iron drug product. Part two focused on the physical and chemical evaluation of the colloidal nature of iron sucrose using a series of characterization experiments: ultracentrifugation, dialysis, particle size, zeta potential, and osmotic pressure analysis. A validated Taguchi-optimized high performance gel permeation chromatography method was used for m.w. determinations. Results indicate m.w. of the iron sucrose complex remained unchanged after excipient dilution, ultracentrifugation, dialysis, and electrolyte dilution. Electrolyte dilution studies indicated the lyophilic nature of the iron sucrose colloid with a particle size of 10nm and zeta potential of 0 mV. The complex deformed at low pH and reformed back at the formulation pH. The complex is stable under mild-to-moderate temperature <50°C but aggregates following prolonged exposure to high temperatures >70°C. In conclusion, the resistance of the complex to breakdown by electrolytic conditions, excipient dilution, ultracentrifugation and the reversible complexation after alteration of formulation pH suggest iron sucrose is a lyophilic colloid in nature and lyophilic colloidals are thermodynamically stable.

摘要

研究目的是评估铁蔗糖复合物的热力学稳定性,方法是通过分子量(m.w.)变化来确定。研究的第一部分侧重于热应力、pH 值、电解质或赋形剂稀释对胶体铁药物产品稳定性的影响。第二部分侧重于使用一系列特性实验(超速离心、透析、粒径、Zeta 电位和渗透压分析)对铁蔗糖的胶体性质进行物理化学评估。采用经过验证的 Taguchi 优化高效凝胶渗透色谱法进行 m.w. 测定。结果表明,赋形剂稀释、超速离心、透析和电解质稀释后铁蔗糖复合物的 m.w. 保持不变。电解质稀释研究表明,铁蔗糖胶体具有亲水性,粒径为 10nm,Zeta 电位为 0mV。该复合物在低 pH 值下变形,并在制剂 pH 值下重新形成。该复合物在温和至中等温度(<50°C)下稳定,但在长时间暴露于高温(>70°C)后会聚集。总之,复合物对电解质条件、赋形剂稀释、超速离心以及制剂 pH 值改变后的可逆络合的抵抗力表明,铁蔗糖本质上是一种亲水性胶体,亲水性胶体在热力学上是稳定的。

相似文献

1
Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose.胶体铁药物产品(蔗糖铁)的药物特征描述和热力学稳定性评估
Int J Pharm. 2014 Apr 10;464(1-2):46-52. doi: 10.1016/j.ijpharm.2014.01.008. Epub 2014 Jan 17.
2
Thermodynamic stability assessment of a colloidal iron drug product: sodium ferric gluconate.胶体铁药物产品(葡甲酸钠铁)的热力学稳定性评估。
J Pharm Sci. 2010 Jan;99(1):142-53. doi: 10.1002/jps.21806.
3
Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.铁碳水化合物胶体药物制剂的理化特性分析。
AAPS J. 2017 Sep;19(5):1359-1376. doi: 10.1208/s12248-017-0126-0. Epub 2017 Jul 31.
4
Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.通过低温透射电子显微镜对静脉注射铁络合物的核心尺寸测定和结构表征
Int J Pharm. 2016 May 30;505(1-2):167-74. doi: 10.1016/j.ijpharm.2016.03.029. Epub 2016 Mar 18.
5
Iron sucrose: assessing the similarity between the originator drug and its intended copies.蔗糖铁:评估原创药物与其预期仿制品之间的相似性。
Ann N Y Acad Sci. 2017 Nov;1407(1):63-74. doi: 10.1111/nyas.13517.
6
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.铁-蔗糖制剂的理化性质和结构特征:比较研究。
Pharm Dev Technol. 2014 Aug;19(5):513-20. doi: 10.3109/10837450.2013.795171. Epub 2013 May 24.
7
Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.评价铁纳米颗粒药物产品的物理化学性质:品牌和通用型葡甲酸钠铁。
Mol Pharm. 2021 Apr 5;18(4):1544-1557. doi: 10.1021/acs.molpharmaceut.0c00922. Epub 2021 Feb 23.
8
A robust and easily reproducible protocol for the determination of size and size distribution of iron sucrose using dynamic light scattering.使用动态光散射法测定蔗糖铁粒径大小及分布的稳健且易于重现的方案。
J Pharm Biomed Anal. 2018 Apr 15;152:89-93. doi: 10.1016/j.jpba.2018.01.029. Epub 2018 Jan 31.
9
Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.静脉注射蔗糖铁和类似蔗糖铁在产后和妇科手术患者中的不良事件谱比较。
Curr Med Res Opin. 2013 Feb;29(2):141-7. doi: 10.1185/03007995.2012.760444. Epub 2013 Jan 8.
10
Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD).通过电子衍射(ED)和 X 射线粉末衍射(XRPD)对治疗缺铁性贫血的九种不同的肠外药物中铁氧化物/氢氧化物纳米颗粒的结构进行表征。
J Pharm Biomed Anal. 2013 Dec;86:151-60. doi: 10.1016/j.jpba.2013.08.005. Epub 2013 Aug 14.

引用本文的文献

1
Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.静脉铁-碳水化合物纳米复合物表面特性的关键性:对药代动力学和药效学的影响。
Int J Mol Sci. 2022 Feb 15;23(4):2140. doi: 10.3390/ijms23042140.
2
Pharmaceutical stability of colloidal saccharated iron oxide injection in normal saline.胶体含糖氧化铁注射液在生理盐水中的药物稳定性。
J Pharm Health Care Sci. 2018 Jul 25;4:21. doi: 10.1186/s40780-018-0116-0. eCollection 2018.
3
Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
铁碳水化合物胶体药物制剂的理化特性分析。
AAPS J. 2017 Sep;19(5):1359-1376. doi: 10.1208/s12248-017-0126-0. Epub 2017 Jul 31.
4
How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.CDER 如何为纳米革命做好准备?风险评估、监管研究和指导活动回顾。
AAPS J. 2017 Jul;19(4):1071-1083. doi: 10.1208/s12248-017-0084-6. Epub 2017 Apr 18.